Marcelo Capra

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 132 citations

Hematological Malignancy, Frontline Bortezomib, Lymphoid Neoplasia +13

DBS Sampling in Imatinib Therapeutic Drug Monitoring: from Method Development to Clinical Application

Marina Venzon Antunes, Suziane Raymundo, Sandrine Comparsi Wagner et al. · Bioanalysis · 2015 · 39 citations

Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil

Marcelo Capra, Líbia Vilella, Waldir Veiga Pereira et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 23 citations

Monitoring imatinib plasma concentrations in chronic myeloid leukemia

Darlize Hübner Martins, Sandrine Comparsi Wagner, Tamyris Vianna dos Santos et al. · Revista Brasileira de Hematologia e Hemoterapia · 2011 · 22 citations · Full text

First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemia

Arnaud Capron, Marina Venzon Antunes, Sandrine Comparsi Wagner et al. · Clinica Chimica Acta · 2015 · 12 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Laboratory Hematology +12